Considering the Role of Estradiol in the Psychoneuroimmunology of Perimenopausal Depression

Overview

Journal Brain Behav Immun Health

Date 2024 Aug 20

PMID 39161877

Authors

Erin Bondy

Affiliations

Soon will be listed here.

Abstract

In recent years, a burgeoning field of research has focused on women's mental health and psychiatric conditions associated with perinatal and postpartum periods. An emerging trend points to the link between hormone fluctuations during pregnancy and postpartum that have immunologic consequences in cases of perinatal depression and postpartum psychosis. The transition to menopause (or "perimenopause") has garnered comparatively less attention, but existing studies point to the influential interaction of hormonal and immune pathways. Moreover, the role of this cross talk in perturbing neural networks has been implicated in risk for cognitive decline, but relatively less work has focused on the depressed brain during perimenopause. This brief review brings a psychoneuroimmunology lens to depression during the perimenopausal period by providing an overview of existing knowledge and suggestions for future research to intertwine these bodies of work.

References

Furtado M, Katzman M . Examining the role of neuroinflammation in major depression. Psychiatry Res. 2015; 229(1-2):27-36. DOI: 10.1016/j.psychres.2015.06.009. View

Karsch F, Battaglia D, Breen K, Debus N, Harris T . Mechanisms for ovarian cycle disruption by immune/inflammatory stress. Stress. 2002; 5(2):101-12. DOI: 10.1080/10253890290027868. View

Meyer J, Cervenka S, Kim M, Kreisl W, Henter I, Innis R . Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020; 7(12):1064-1074. PMC: 7893630. DOI: 10.1016/S2215-0366(20)30255-8. View

Sturgeon J, Darnall B, Zwickey H, Wood L, Hanes D, Zava D . Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status. J Pain Res. 2014; 7:707-16. PMC: 4259557. DOI: 10.2147/JPR.S71344. View

McCarthy M, Raval A . The peri-menopause in a woman's life: a systemic inflammatory phase that enables later neurodegenerative disease. J Neuroinflammation. 2020; 17(1):317. PMC: 7585188. DOI: 10.1186/s12974-020-01998-9. View

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio R . Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. PLoS One. 2017; 12(10):e0185926. PMC: 5634623. DOI: 10.1371/journal.pone.0185926. View

Ha D, Xu J, Janowsky J . Preliminary evidence that long-term estrogen use reduces white matter loss in aging. Neurobiol Aging. 2006; 28(12):1936-40. PMC: 2151930. DOI: 10.1016/j.neurobiolaging.2006.08.007. View

Honjo H, Tanaka K, Urabe M, Naitoh K, Ogino Y, Yamamoto T . Menopause and hyperlipidemia: pravastatin lowers lipid levels without decreasing endogenous estrogens. Clin Ther. 1992; 14(5):699-707. View

Villa A, Vegeto E, Poletti A, Maggi A . Estrogens, Neuroinflammation, and Neurodegeneration. Endocr Rev. 2016; 37(4):372-402. PMC: 4971309. DOI: 10.1210/er.2016-1007. View

10.

de Kruif M, Spijker A, Molendijk M . Depression during the perimenopause: A meta-analysis. J Affect Disord. 2016; 206:174-180. DOI: 10.1016/j.jad.2016.07.040. View

11.

Liang G, Kow A, Yusof R, Tham C, Ho Y, Lee M . Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System-A Review. Biomedicines. 2024; 12(1). PMC: 10813042. DOI: 10.3390/biomedicines12010184. View

12.

Szpunar M, Malaktaris A, Baca S, Hauger R, Lang A . Are alterations in estradiol, cortisol, and inflammatory cytokines associated with depression during pregnancy and postpartum? An exploratory study. Brain Behav Immun Health. 2021; 16:100309. PMC: 8474549. DOI: 10.1016/j.bbih.2021.100309. View

13.

Rudzinskas S, Hoffman J, Martinez P, Rubinow D, Schmidt P, Goldman D . In vitro model of perimenopausal depression implicates steroid metabolic and proinflammatory genes. Mol Psychiatry. 2020; 26(7):3266-3276. PMC: 7878574. DOI: 10.1038/s41380-020-00860-x. View

14.

Lamers F, Milaneschi Y, Smit J, Schoevers R, Wittenberg G, Penninx B . Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety. Biol Psychiatry. 2019; 85(10):829-837. DOI: 10.1016/j.biopsych.2018.12.020. View

15.

Hoyt L, Falconi A . Puberty and perimenopause: reproductive transitions and their implications for women's health. Soc Sci Med. 2015; 132:103-12. PMC: 4400253. DOI: 10.1016/j.socscimed.2015.03.031. View

16.

Najjar F, Ahmad M, Lagace D, Leenen F . Sex differences in depression-like behavior and neuroinflammation in rats post-MI: role of estrogens. Am J Physiol Heart Circ Physiol. 2018; 315(5):H1159-H1173. PMC: 6297826. DOI: 10.1152/ajpheart.00615.2017. View

17.

Zhang W, Guo Y, Wang K, Chen L, Jiang P . Neuroprotective effects of vitamin D and 17ß-estradiol against ovariectomy-induced neuroinflammation and depressive-like state: Role of the AMPK/NF-κB pathway. Int Immunopharmacol. 2020; 86:106734. DOI: 10.1016/j.intimp.2020.106734. View

18.

Zainal N, Newman M . Prospective network analysis of proinflammatory proteins, lipid markers, and depression components in midlife community women. Psychol Med. 2022; 53(11):5267-5278. PMC: 9898473. DOI: 10.1017/S003329172200232X. View

19.

Santoro N . Perimenopause: From Research to Practice. J Womens Health (Larchmt). 2015; 25(4):332-9. PMC: 4834516. DOI: 10.1089/jwh.2015.5556. View

20.

Maki P, Kornstein S, Joffe H, Bromberger J, Freeman E, Athappilly G . Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018; 25(10):1069-1085. DOI: 10.1097/GME.0000000000001174. View